PBM Transparency Act Advances In Senate And It’s A Far Cry From The Rebate Rule

Bill aims to lower patient costs in part by engaging the US Federal Trade Commission to shed light on pharmacy benefit manager transactions with health plans, manufacturers and pharmacies.